[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.172.216.157. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Views 223
Citations 0
Comment & Response
March 2019

Low-Dose Amitriptyline for Chronic Low Back Pain

Author Affiliations
  • 1Institute for Musculoskeletal Health, Sydney School of Public Health, Faculty of Health and Medicine, The University of Sydney, Sydney, Australia
  • 2Sydney Pharmacy School, Faculty of Health and Medicine, The University of Sydney, Sydney, Australia
JAMA Intern Med. 2019;179(3):450. doi:10.1001/jamainternmed.2018.8140

To the Editor We thank Dr Urquhart and colleagues for their recent trial of low-dose amitriptyline in people with chronic low back pain.1 However, the interpretation of their findings—that amitriptyline may be an effective treatment for chronic low back pain and a possible strategy to avoid using opioid analgesics—is problematic as it is not supported by the data presented.

Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×